Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent.
Journal: Cancer chemotherapy and pharmacology
Published: April 12, 2017
De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients.
Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Published: May 12, 2015
Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers.
Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Published: November 20, 2014
Pseudomembranes do not always indicate Clostridium difficile infection.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 25, 2014
Targeted therapy in gastrointestinal malignancies.
Journal: Journal of carcinogenesis
Published: October 05, 2013
Erlotinib and radiation therapy for elderly patients with esophageal cancer - clinical and correlative results from a prospective multicenter phase 2 trial.
Journal: Oncology
Published: March 12, 2013
Showing 1-6 of 6
Last Updated: 09/26/2026